Authors


Marissa Fors LCSW, OSW-C, C-ASWCM, CCM

Latest:

Opinion: Drama Therapy Can Be a Therapeutic Tool for Helping Patients Cope With Cancer

Drama therapy may be a unique approach to help patients with cancer express themselves and improve their emotional well-being. It can also help health care professionals improve their communication skills.


Fran Cartwright, RN, PhD, AOCN

Latest:

Fran Cartwright on the Importance of Pain Management

Fran Cartwright, PhD, RN-BC, AOCN, Senior Director of Nursing, Oncology Services and Medicine, NYU Langone Medical Center, discusses the importance of understanding the many facets of pain management.


Virginia LeBaron, APRN, PhD, FAANP

Latest:

Don't Just Do Something, Stand There: The Power of 'The Pause'

Sometimes the most productive thing we can do is to stop.


Jason Harris

Latest:

Cemiplimab Shows Clinical Benefit for Patients With PD-L1+ NSCLC and Brain Metastases

At a median follow-up of 33.3 months, the median overall survival was not evaluable with cemiplimab, vs 20.7 months with chemotherapy alone, in this patient subset.


Patti Bradfield

Latest:

Parents and Loved Ones: The Unsung Heroes

We need to either do away with the pink or change the color for inflammatory breast cancer (IBC), because it's not at all pink. It's black and blue, purple, and sometimes just plain red.


Jasmine Greenamyer

Latest:

Never Too Young

We were thrilled to cohost the Colorectal Cancer Survivor Panel Lunch & Learn at the recent OMG! Cancer Summit for Young Adults with our friends at Chris4Life.


Andrea Nicholson, MPH

Latest:

The Universal Language of Caring

Language barriers can mean patients put off preventive screenings, and even treatment, for fear of being misunderstood by their healthcare providers.


OncLive Nursing

Latest:

New Toxicity Grading Criteria Help Standardize Management of CAR T-Cell Therapy-Related AEs

Newly standardized grading criteria will help to regulate the management of CAR T-cell therapy¬–related toxicities, like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).


Guillermo Garcia-Manero, MD

Latest:

Trial To Evaluate Eprenetapopt-Azacytidine Combo in TP53+ MDS Completes Enrollment

A phase 3 trial designed to evaluate eprenetapopt plus azacytidine (Vidaza) in patients with TP53-mutant positive myelodysplastic syndrome (MDS) completed full enrollment, according to Aprea Therapeutics, Inc.


Jan S. Lewin, PhD

Latest:

Head and Neck Lymphedema Is More than a Cosmetic Problem

Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.


Nickhill Bhakta, MD

Latest:

Nickhill Bhakta Discusses Unanswered Questions About Survivors of Childhood Cancer

Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses some unanswered questions about late effects of adult survivors of childhood cancer.


Stephanie Buia Amport, MBA, CPHQ

Latest:

Improving Safety and Quality with Oral Chemotherapy

Over the past several years, process improvements in the care of our oncology patients have been implemented that focus on the provision of safe and high quality clinical care and employee safety.



Claire Snyder, MHS, PhD

Latest:

Claire Snyder on Patient-Reported Outcome Questionnaires

Claire Snyder, MHS, PhD, associate professor of medicine and oncology with a joint appointment in health policy and management at Johns Hopkins School of Medicine, discusses patient-reported outcome assessments and standardization of questionnaires.


Jyoti Patel, MD

Latest:

Dr. Jyoti Patel on Delaying Whole Brain Radiation for Brain Metastases

Jyoti Patel, MD, of Northwestern University's Feinberg School of Medicine, talks about the subject of delaying whole brain radiation for brain metastases.


Ragini Kudchadkar, MD

Latest:

Ragini Kudchadkar on Treating Patients with Basal Cell Carcinoma

Ragini Kudchadkar, MD, explains what nurses should keep in mind when treating patients with basal cell carcinoma.


Rajni Kannan, BS, MS, RN, ANP-BC

Latest:

Rajni Kannan on Risk Factors for Melanoma

Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.


Sarah Gallups, PhD, MPH, RN

Latest:

Structuring a Study of Interpersonal Communication in Breast Cancer Navigation

A team of researchers at the University of Pittsburgh School of Nursing set out to better understand the interpersonal communication components of breast cancer navigation services.


Kathleen Wolf, RN, BSN, MBA, NEA-BC

Latest:

Kathleen Wolf on Navigating Difficult Conversations with Patients

Kathleen Wolf, RN, BSN, MBA, NEA-BC, discuss how nurses can tackle difficult conversations with patients.


Colleen OLeary, MSN

Latest:

Colleen O'Leary Describes Chemotherapy Safety

Colleen OLeary from James Cancer Hospital Describes Chemotherapy Safety Standards


Beth Dailey, BSN, RN, OCN, HN-BC

Latest:

Beth Dailey on Helping Nurses Work Smarter, Not Harder

Beth Dailey, BSN, RN, OCN, HN-BC, from Cancer Treatment Centers of America at Eastern Regional Medical Center (ERMC), discusses how suggestions from nurses helped a merged clinic staff work smarter.


Hope Rugo, MD

Latest:

Expert Discusses The Value of Combination Treatment in TNBC Treatment

The future of treating patients with triple-negative breast cancer is bright, but more needs to be done to address mutations early on in the course of the disease.


Jackie Doss

Latest:

Surviving Stage IV Melanoma With Vigilance and Hope

In February 2002, I was diagnosed with stage I melanoma.


Lauren Chatalian, LMSW, Women & Children

Latest:

Navigating Breast Cancer Care During a Pandemic

While COVID-19 continues to present much uncertainty for many people, those diagnosed with breast cancer are faced with unique challenges in navigating continued treatment.


Kaitlen Francese, RN

Latest:

Kaitlyn Francese on Getting Patients to Discuss Side Effects

Kaitlyn Francese, RN, a research nurse at NYU Langone Medical Center, discusses the difficulty she faces in getting patients on clinical trials to talk about their side effects.


Suman Kambhampati, MD

Latest:

Expert Discusses Recent CLL Approval

The recent approval of ibrutinib plus obinutuzumab is a major advancement in the chronic lymphocytic leukemia space.


Alan Astrow, MD

Latest:

Alan Astrow Highlights the Importance of Listening to Patients

Dr. Alan Astrow discusses the importance of clinicians listening to all of a patient's concerns.


Clifford A. Hudis, MD

Latest:

Dr. Hudis on the Challenges of Understanding Obesity and Cancer

Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the challenges of understanding the link between obesity and cancer.


CEO

Latest:

Nurses Can Address Psychosocial Needs, From Diagnosis to Survivorship

The September issue of Oncology Nursing News® offers a wealth of information on how oncology nurses can help their patients navigate psychosocial issues, from the moment of diagnosis and beyond.


Patricia Jakel, MN, RN AOCN
Patricia Jakel, MN, RN, AOCN

Latest:

The Changing Landscape of Clinical Trials in Cancer Care

Although excitement surrounds the constantly changing landscape of cancer care, we have much to learn to keep our practices current.

© 2024 MJH Life Sciences

All rights reserved.